Page 948 and Cover Sheet of "Cardiac and Vascular Diseases" by Conn and Horwitz, vol. II by Lea and Febiger, Philadelphia (1971). |
Drugs 23: 195-206 (1982); Review Article by Robert Wilkinson; Title: "Beta-Blockers and Renal Function". |
Ljungman S., et al., Blood Pressure and Renal Function, Acta Med. Scand. 208, 17-25, (1980). |
Epstein M., et al., Beta-Blockers and the Kidney, Min. Electrolyte Metab. 8, 237-254 (1982). |
Berglung G., et al., Pharmacokinetics of Sotalol after Chronic Administration to Patients with Renal Insufficiency, Eur. J. Clin. Pharmacol, 18, 321-326, (1980). |
Bianchi G., et al., A Renal Abnormality as a possible cause of "Essential" Hypertension, Lancet I, 173-177, (1979). |
Bianchi, G., et al., Renal Dysfunction as a possible cause of Essential Hypertension in Predisposed Subjects, Kidney Int. 23, 870-875, (1983). |
Hollenberg N. K., et al., "No Man's Land" of the Renal Vasculature, An Arteriographic and Hemodynamic Assessment in the Interlobar and Arcuate Arteries in Essential and Accelerated Hypertension, Am. J. Med. 47, 845-852, (1969). |
Danesh B. J. Z., et al., Nadolol and Renal Haemodynamics, Proc. R. Soc. Med. 37, 87-95 (1981). |
Warren D., et al., Deterioration in Renal Function after Beta-Blockade in Patients with Chronic Renal Failure and Hypertension, Br. Med., J. 2, 193-194 (1974). |
Swainson C. P., et al., Effect of Beta Blockade in Chronic Renal Failure, Br. Med. J. 459, (1976). |
Leary W. P., et al., Effect of Beta-Blocking Agents on Renal Function, S. Afr. Med. J. 56, 745 (1979). |
O'Connor D. T., et al., Preserved Renal Perfusion during Treatment of Essential Hypertension with the Beta-Blocker Nadolol, J. Clin. Pharmacol. 22, 187-195, (1982). |
Britton K. E., et al., Nadolol and Renal Haemodynamics, Proc. R. Soc. Med. 37, 77-85, (1981). |
Pedersen E. B.: Glomerular Filtration Rate and Renal Plasma Flow in Patients with Essential Hypertension before and after Treatment with Alprenolol, Acta Med. Scand. 198, 365-371, (1975). |
Wilcox C. S., et al., Renal Function, Body Fluid Volumes, Renin, Aldosterone, and Noradrenaline during Treatment of Hypertension with Pindolol, J. Cardiovasc. Pharmacol. 3, 598-611, (1981). |
Zech P. Y., et al., Response to Atenolol in Arterial Hypertension in Relation to Renal Function, Pharmacokinetics and Renin Activity, Postgrad. Med. J. 53, suppl. 3, 134-141, (1977). |
Wilkinson R., et al., A Study of the Effects of Atenolol and Propranolol on Renal Function in Patients with Essential Hypertension, Br. J. Clin. Pharmaco. 10, 51-59, (1980). |
O'Connor D. T., et al., Urinary Kallikrein Activity, Renal Hemodynamics, and Electrolyte Handling During Chronic Beta Blockade with Propanolol in Hypertension, Hypertension 4, 742-749, (1982). |
Pedersen, E. B.: Effect of Sodium Loading and Exercise on Renal Haemodynamics and Urinary Sodium Excretion in Young Patients with Essential Hypertension Before and During Propranolol Treatment, Acta Med. Scand. 201, 365-373, (1977). |
Warren, S. E., et al., Renal Hemodynamic Changes During Long-Term Antihypertensive Therapy, Clin. Pharmacol. Ther. 29, 310-317 (1981). |
O'Connor, D. T., et al., Renal Perfusion Changes During Treatment of Essential Hypertension: Prazosin versus Propranolol, J. cardiovas. Pharmacol., suppl. 1, 38-42, (1979). |
Bauer, J. H., et al., The Long-Term Effect of Propranolol Therapy on Renal Function, Am. J. Med. 66, 405-410, (1979). |